Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

MIR200CHG for gastric cancer metastasis

March 26, 2024 7:44 PM UTC

Delivery of the long-coding RNA (lncRNA) MIR200CHG, which is silenced in gastric cancer via promoter hypermethylation, could help prevent metastasis by binding to and stabilizing the microRNA miR-200c to decrease epithelial-to-mesenchymal transition (EMT).

Bioinformatic analyses of public gastric cancer transcriptomic datasets showed that tumors with a higher EMT gene expression signature had worse overall survival; further analyses of lncRNA regulator networks within this signature identified MRC200CHG as the most down-regulated lncRNA in EMT-high tumors, and lower tumor expression of MRC200CHG in these patients was associated with worse overall survival. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article